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Abstract 
Unbalanced 1q rearrangements are widely reported 
in myeloid and lymphoid malignancies. Among 
unbalanced translocations of 1q, der(4)t(1;4)(q11-
32;q34-q35) resulting in complete or partial  
trisomies of genes located on 1q is a relatively rare 
anomaly. 
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Figure 1.  Partial karyotypes with unbalanced translocation between chromosomes 1 and 4 (A). Fluorescence in situ 
hybridization with LSI 1p36/1q25 dual color probe (Abott Molecular/Vysis, US) showing the extra copy of 1q (green signal) on 
der(4) chromosome (B). 
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Clinics and pathology 
Disease 
Myeloid malignancies, multiple myeloma (MM) and 
Non-Hodgkin lymphoma.  
 Myeloid malignancies  in 4 (4 males aged 1 to 30 
years): 1 refractory anemia with excess blasts-2 
(Vundinti et al., 2003), 1 acute myeloblastic 
leukemia with minimal differentiation (AML-M0) 
(Creutzig et al., 1996), 1 acute erythroleukemia 
(AML-M6) (Baumgarten et al., 1993) and 1 acute 
megakaryoblastic leukemia (AML-M7) (Martinez-
Climent et al., 1995). 3 of the AML patients were 
children with Down syndrome (DS) (aged 1, 2 and 2 
years) (Baumgarten et al., 1993; Martinez-Climent et 
al., 1995; Creutzig et al., 1996).  
 Multiple myeloma  in 7 (4 males and 3 females; 
ages unknown) (Sawyer et al., 1998; Sawyer et al., 
1998; Gutierrez et al., 2000; Lloveras et al.,2004; 
Wu et al., 2007; Sawyer et al., 2014; Rack et al., 
2016).  
Lymphoid malignancies 1 acute lymphoblastic 
leukemia  (Lin et al., 1990) (1 female aged 11 years), 
1 post-transplant lymphoproliferative disorder (1 
male aged 42 years) (Djokic et al., 2006); 10 B-cell 
lymphomas  (6 males and 4 females aged 39 to 74 
years), among them  6 patients with follicular 
lymphoma (Nishida et al., 1989; Bastard et al., 1992; 
Gray et al., 1997; Itoyama et al., 2002; Aamot et al., 
2007; Narayan et al., 2013), 2 with diffuse large B-
cell lymphoma (DLBCL) (Le Baccon et al., 2001; 
Trcic et al., 2010), 2 with mature B-cell neoplasm 
(Morgan et al., 1999; Veldman et al., 1997) and there 
was an 14 years old female with T-cell anaplastic 
large cell lymphoma (Lones et al., 2006). 
Epidemiology 
15 males and 9 females aged 1 to 74 years (median 
42 years). 
Prognosis 
Reported patients are characterized by complex 
karyotypes that likely reflects an inherent 




Various breakpoints on the long arm of chromosome 
1; MM and lymphoma patients tend to have more 
frequently near-centromeric 1q breakpoints (4 out of 
7 MM and 7 out of 10 B-cell lymphoma patients). 
Additional anomalies 
Sole anomaly in 1 patient with DLBCL (Trcic et al., 
2010), found in association with +8 in 2 AML 
patients with Down syndrome (DS) (Baumgarten et 
al., 1993; Creutzig et al., 1996) and in 1 with 
i(7)(q10) (Martinez-Climent et al., 1995). Found in a 
sideline with i(7)(q10) and t(9;22)(q34;q11) in the 
ALL patient (Lin et al., 1990), t(14;18)(q32;q21), as 
a part of complex karyotypes in 7 out of 10 B-cell 
lymphomas (Nishida et al., 1989; Bastard et al., 
1992; Morgan et al., 1999; Le Baccon et al., 2001;  
Itoyama et al., 2002; Aamot et al., 2007; Narayan et 
al., 2013) and as an additional anomaly to 
t(2;5)(p23;q35) in patient with anaplastic large cell 
lymphoma (Lones et al., 2006). Found with 
del(1)(q21) in 1 (Gutierrez et al., 2000) and as part 
of highly complex karyotypes in the remaining 
multiple myeloma patients. 




1q gains represent nonrandom structural aberrations 
in hematological malignancies, suggesting the 
existence of genes in this chromosomal region that 
are important for disease initiation and/or 
progression.  
Chromosome arm 1q is gene-rich, therefore several 
genes on 1q may contribute to disease pathogenesis 
that might cooperate in an additive or synergistic 
way resulting in their simultaneous downregulation. 
der(4)t(1;4)(q11-32;q34-35) has been reported as a 
sole karyotype aberration only in one patient, while 
it is usually present with additional common 
abnormalities or along with complex combinations 
of anomalies in most of the reported cases, indicating 
that gain of 1q might be relevant for tumor 
progression and advanced disease. 
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